Article info
PDFCurrent controversy
WHO’s allocation framework for COVAX: is it fair?
- Correspondence to Dr Siddhanth Sharma, Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA; siddhanth_sharma{at}hsph.harvard.edu
Citation
WHO’s allocation framework for COVAX: is it fair?
Publication history
- Received December 9, 2020
- Revised March 11, 2021
- Accepted March 21, 2021
- First published April 9, 2021.
Online issue publication
November 16, 2022
Article Versions
- Previous version (16 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Vaccine equity in COVID-19: a meta-narrative review
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- Love thy neighbour? Allocating vaccines in a world of competing obligations
- Towards a new model of global health justice: the case of COVID-19 vaccines
- It is not too late to achieve global covid-19 vaccine equity
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review
- Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?